Financials Vext Science, Inc.

Equities

VEXT

CA9255401064

Healthcare Facilities & Services

Market Closed - Canadian Securities Exchange 03:59:55 2024-04-29 pm EDT 5-day change 1st Jan Change
0.24 CAD 0.00% Intraday chart for Vext Science, Inc. -2.04% -17.24%

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Capitalization 1 89.5 69.2 26.37 43.15 43.15 -
Enterprise Value (EV) 2 89.5 76.84 58.59 71.25 83.45 43.15
P/E ratio 39.5 x - - -12 x -12 x -
Yield - - - - - -
Capitalization / Revenue 3.55 x 1.86 x 0.74 x 1.22 x 0.9 x 0.64 x
EV / Revenue 3.55 x 2.06 x 1.65 x 2.01 x 1.75 x 0.64 x
EV / EBITDA 13.1 x 5.74 x 3.88 x 10.3 x 6.22 x 1.97 x
EV / FCF -9.13 x -10.8 x -19.9 x 6.96 x 21.1 x 3.36 x
FCF Yield -11% -9.24% -5.01% 14.4% 4.74% 29.8%
Price to Book - - - - - -
Nbr of stocks (in thousands) 115,153 136,713 148,963 245,451 245,451 -
Reference price 3 0.9900 0.6400 0.2400 0.2400 0.2400 0.2400
Announcement Date 4/15/21 4/20/22 3/22/23 - - -
1CAD in Million2USD in Million3CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 25.19 37.24 35.41 35.38 47.74 67.87
EBITDA 1 6.813 13.39 15.12 6.891 13.42 21.89
EBIT 1 4.686 - - 0.419 - -
Operating Margin 18.6% - - 1.18% - -
Earnings before Tax (EBT) 2.639 - - - - -
Net income 2.125 - - - - -
Net margin 8.43% - - - - -
EPS 2 0.0251 - - -0.0200 -0.0200 -
Free Cash Flow 1 -9.803 -7.102 -2.938 10.23 3.957 12.84
FCF margin -38.91% -19.07% -8.3% 28.93% 8.29% 18.92%
FCF Conversion (EBITDA) - - - 148.53% 29.49% 58.66%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 4/15/21 4/20/22 3/22/23 - - -
1USD in Million2CAD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 9.376 9.4 9.308 10.79 8.766 7.673 8.181 9.111 9.187 8.099 8.975 9.642 9.674 10.91 13.87
EBITDA 1 3.436 3.568 3.37 3.887 4.847 3.279 3.181 2.931 1.049 1.077 2.08 2.596 2.718 3.276 4.29
EBIT 2.303 1.689 - - - - - - - - - - - - -
Operating Margin 24.56% 17.97% - - - - - - - - - - - - -
Earnings before Tax (EBT) - - - - - - - - - - - - - - -
Net income - - - - - - - - - - - - - - -
Net margin - - - - - - - - - - - - - - -
EPS 2 - - - - - - - - - -0.0136 -0.0100 - - - -
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 8/24/21 11/18/21 4/20/22 5/30/22 8/24/22 11/17/22 3/22/23 5/25/23 8/23/23 11/28/23 - - - - -
1USD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt 1 - 7.64 32.2 28.1 40.3 -
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - 0.57 x 2.131 x 4.078 x 3.004 x -
Free Cash Flow 1 -9.8 -7.1 -2.94 10.2 3.96 12.8
ROE (net income / shareholders' equity) 6.86% 12.8% 13.6% 9.7% 5.4% -
ROA (Net income/ Total Assets) 4.51% 8.82% 8.75% 9% 6.1% -
Assets 47.12 - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share 2 - 0.1000 0.0600 0.0900 0.0500 -
Capex 1 4.06 18.8 8.86 5.22 3.71 1.86
Capex / Sales 16.13% 50.43% 25.02% 14.74% 7.78% 2.75%
Announcement Date 4/15/21 4/20/22 3/22/23 - - -
1USD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
0.24 CAD
Average target price
0.7333 CAD
Spread / Average Target
+205.55%
Consensus
  1. Stock Market
  2. Equities
  3. VEXT Stock
  4. Financials Vext Science, Inc.